Study in Patients With Advanced Cancers Associated With Expression of DLL3
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04471727 |
|
Recruitment Status :
Recruiting
First Posted : July 15, 2020
Last Update Posted : December 12, 2023
|
Sponsor:
Harpoon Therapeutics
Information provided by (Responsible Party):
Harpoon Therapeutics
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | January 2024 |
| Estimated Study Completion Date : | June 2024 |